TPEQM-DMA, a NIR-II photosensitizer, selectively accumulates in cancerous mitochondria and demonstrates potent type-I phototherapeutic efficacy that inhibits the growth of cancer cells. This efficacy aids in overcoming the intrinsic limitations of photodynamic therapy (PDT) in treating hypoxic tumors [1].
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
